|
|
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESLANGLEY, BC / ACCESSWIRE / March 3, 2023 / Adastra Holdings Ltd. CSE:XTRXFRA:D2EP "Adastra" or the "Company", a leading cannabis company focused on processing, adultuse and medical sales, organoleptic testing and analytical testing, retracts the statements in its news release dated... Lire le communiqué |
|
| |
|
| |
|
|
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESLANGLEY, BC / ACCESSWIRE / February 22, 2023 / Adastra Holdings Ltd. CSE:XTRXFRA:D2EP "Adastra" or the "Company", a leading cannabis company focused on processing, adultuse and medical sales, organoleptic testing and analytical testing, is pleased to... Lire le communiqué |
|
| |
|
| |
|
|
LANGLEY, BC / ACCESSWIRE / February 14, 2023 / Adastra Holdings Ltd. CSE:XTRXFRA:D2EP "Adastra" or the "Company", a leading cannabis company and producer of two top Canadian concentrate brands, with a focus on processing, adultuse and medical sales, organoleptic and analytical testing, today announced that Lachlan McLeod, CPA of Fehr & Associates, has been appointed Chief... Lire le communiqué |
|
| |
|
| |
|
|
LANGLEY, BC / ACCESSWIRE / February 9, 2023 / Adastra Holdings Ltd. CSE:XTRXFRA:D2EP "Adastra" or the "Company" a leading cannabis company and producer of two top Canadian concentrate brands, with a focus on processing, adultuse and medical sales, organoleptic and analytical testing, announces the termination of a legacy supply agreement for the Companys Phyto Extractions... Lire le communiqué |
|
| |
|
| |
|
|
Record gross revenues of $9.14M YTD 2022, representing 151% growth compared to YTD 2021Q3 2022 gross revenues of $3.80M, representing an increase of 25% over last quarter Q2 2022LANGLEY, BC / ACCESSWIRE / December 1, 2022 / Adastra Holdings Ltd. CSE:XTRXFRA:D2EP "Adastra" or the "Company", a lead... Lire le communiqué |
|
| |
|
| |
|
|
LANGLEY, BC / ACCESSWIRE / August 31, 2022 / Adastra Holdings Ltd. CSE:XTRX FRA:D2EP "Adastra" or the "Company", a leading cannabis company focused on processing, adultuse and medical sales, organoleptic testing and analytical testing, is pleased to announce that the Company has received its Controlled Drug and Substances Dealers License "Dealers License" on August... Lire le communiqué |
|
| |
|
| |
|
|
LANGLEY, BC / ACCESSWIRE / August 30, 2022 / Adastra Holdings Ltd. CSE:XTRXFRA:D2EP "Adastra" or the "Company" is pleased to announce it has entered into an agreement effective August 30, 2022, with a third party the "Agreement", whereby Adastra has the right and option to terminate an exclusive amended license agreement dated December 4, 2020 the "Phyto License... Lire le communiqué |
|
| |
|
| |
